Envestnet Asset Management Inc. Raises Stock Holdings in Waters Co. (NYSE:WAT)

Envestnet Asset Management Inc. increased its stake in shares of Waters Co. (NYSE:WAT - Free Report) by 7.3% in the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 120,167 shares of the medical instruments supplier's stock after purchasing an additional 8,130 shares during the period. Envestnet Asset Management Inc. owned 0.20% of Waters worth $44,580,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of WAT. Bank of Jackson Hole Trust purchased a new stake in shares of Waters during the fourth quarter worth approximately $34,000. Fortitude Family Office LLC grew its stake in Waters by 235.7% during the 4th quarter. Fortitude Family Office LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 66 shares in the last quarter. Steward Partners Investment Advisory LLC raised its holdings in Waters by 129.3% in the 4th quarter. Steward Partners Investment Advisory LLC now owns 94 shares of the medical instruments supplier's stock valued at $35,000 after acquiring an additional 53 shares during the last quarter. Murphy & Mullick Capital Management Corp purchased a new position in Waters in the 4th quarter worth approximately $42,000. Finally, EverSource Wealth Advisors LLC boosted its holdings in shares of Waters by 54.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 125 shares of the medical instruments supplier's stock worth $46,000 after purchasing an additional 44 shares during the last quarter. 94.01% of the stock is owned by hedge funds and other institutional investors.

Remove Ads

Wall Street Analyst Weigh In

WAT has been the subject of a number of research analyst reports. JPMorgan Chase & Co. increased their price target on Waters from $380.00 to $390.00 and gave the stock a "neutral" rating in a report on Thursday, March 6th. Bank of America dropped their price target on shares of Waters from $430.00 to $410.00 and set a "neutral" rating for the company in a research report on Thursday, February 13th. Wells Fargo & Company upped their price objective on shares of Waters from $415.00 to $420.00 and gave the stock an "overweight" rating in a report on Thursday, February 13th. Robert W. Baird upgraded shares of Waters from a "neutral" rating to an "outperform" rating and lifted their target price for the company from $396.00 to $407.00 in a report on Wednesday, March 26th. Finally, StockNews.com cut Waters from a "buy" rating to a "hold" rating in a research note on Tuesday, February 25th. Ten analysts have rated the stock with a hold rating, seven have given a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $397.25.

Waters Stock Up 0.1 %

Shares of NYSE:WAT traded up $0.39 on Wednesday, hitting $323.83. 69,302 shares of the company's stock were exchanged, compared to its average volume of 474,954. The company has a debt-to-equity ratio of 1.14, a quick ratio of 0.65 and a current ratio of 0.94. Waters Co. has a 1-year low of $279.24 and a 1-year high of $423.56. The company has a market capitalization of $19.27 billion, a PE ratio of 30.26, a P/E/G ratio of 3.79 and a beta of 1.04. The firm's 50-day moving average is $365.47 and its 200 day moving average is $371.98.

Waters (NYSE:WAT - Get Free Report) last announced its quarterly earnings results on Wednesday, February 12th. The medical instruments supplier reported $4.10 EPS for the quarter, beating the consensus estimate of $4.02 by $0.08. Waters had a net margin of 21.56% and a return on equity of 46.31%. Sell-side analysts predict that Waters Co. will post 12.86 EPS for the current year.

Waters Profile

Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.